Covid-19/Flu Combo Test

LifeSign Status™ COVID-19 Flu A&B Test, 25 Tests/Box

$475.00 $445.00
(You save $30.00)
1.70 LBS
Minimum Purchase:
1 unit
Calculated at Checkout

LifeSign Status™ COVID-19 Flu A&B Combo Test

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens. 

***PLEASE NOTE - Unless you possess a verifiable CLIA number or NPI number requested and submitted during checkout process, you cannot order this product. All orders placed without one will be canceled and refunded.***

As an intended point-of-care (POC) designated test performed by medical professionals. Lifesign COVID-19/Flu A&B test helps provide critical answers about active infections to patients and healthcare workers alike.

A Rapid Point Of Care Test

  • Sensitivity and Specificity
    COVID-19 – Sensitivity 93.9%, Specificity 100%
    Flu A – Sensitivity 91.4%, Specificity 95.7%
    Flu B – Sensitivity 87.6%, Specificity 95.9%
  • FDA Emergency Use Authorization (EUA)
  • Visually read in 15 minutes
  • Flocked nasopharyngeal swab for superior specimen collection and patient comfort

Kit Components

  • 25 Test devices
  • 1 Instruction for Use
Test type: Lateral flow immunoassay
Specimen type: Anterior nasal or nasopharyngeal swab specimens

Turnaround time: 15-20 minutes
FDA status:  Emergency Use Authorization (EUA) Granted
CLIA complexity: Waived
  • Status™ COVID-19/FLU A&B is an antigen test for use with nasopharyngeal swab specimens.
  • Status™ COVID-19/FLU A&B test has been granted emergency use authorization (EUA) by the FDA for use at the point-of-care setting. During the duration of the emergency this test can be performed in a patient care setting that is operating under a CUA Waiver, Certificate of Compliance or Certificate of Accreditation

Product Resources


Related Products